Regulations.gov document
Reference 2 - Draft Guidance on Methylphenidate Hydrochloride re Mallinckrodt…
Supporting & Related Material · FDA-2016-N-3118 · posted Oct 18, 2016
Key facts
| Document ID | FDA-2016-N-3118-0003 |
|---|---|
| Title | Reference 2 - Draft Guidance on Methylphenidate Hydrochloride re Mallinckrodt Pharmaceuticals; Proposal to Withdraw Approval of an Abbreviated New Drug Application for Extended-Release Methylphenidate Tablets |
| Document type | Supporting & Related Material |
| Subtype | Background Material |
| Agency | FDA |
| Docket | FDA-2016-N-3118 |
| Posted | Oct 18, 2016 |
At a glance
- 1–9 Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: